Prótesis metacarpofalángicas de carbón pirolítico. Seguimiento a medio plazo

The prosthesis under study showed good medium-term levels of resistance and biocompatibility. Pain decreased and ROM increased, making it possible for patients to carry out their elementary activities. Intra- and postoperative complications were few and patients were satisfied. Periprosthetic osteolysis was observed in a few cases, but it has not got worse and has remained asymptomatic. The prosthesis presented hereby seem to us the best option available at present to address early to mid-stage chronic disease of the metacarpophalangeal joint, especially in young RA patients and in patients with OA.